DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 4BUPROPION HYDROCHLORIDE
02 1DIETHYLPROPION HYDROCHLORIDE
03 1DIVALPROEX SODIUM
04 1DYANAVEL XR 10
05 1DYANAVEL XR 15
06 1DYANAVEL XR 20
07 1DYANAVEL XR 5
08 1FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE
09 1LAMOTRIGINE
10 1MORPHABOND ER
11 1OXYBUTYNIN CHLORIDE
12 1PRAMIPEXOLE DIHYDROCHLORIDE
13 1REQUIP XL
14 1TEGRETOL-XR
15 1TENUATE DOSPAN
16 3TRAMADOL HYDROCHLORIDE
17 1UROXATRAL
18 3VENLAFAXINE HYDROCHLORIDE
19 2ZILEUTON
20 1ZYFLO CR
01 112546
02 120234
03 121287
04 122008
05 122052
06 122104
07 176667
08 178503
09 190942
10 191272
11 191607
12 191680
13 1200503
14 1201331
15 1201384
16 1202206
17 1202419
18 1202774
19 1202775
20 1202887
21 1206544
22 4210526
23 1211390
24 1211972
25 1214419
01 23No
02 5Yes
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
Drug : FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 76667
Country : US
Patented : No
Drug : ZILEUTON
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 211390
Country : US
Patented : No
Drug : VENLAFAXINE HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 214419
Country : US
Patented : No
Drug : DIVALPROEX SODIUM
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 202419
Country : US
Patented : No
Drug : BUPROPION HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 90942
Country : US
Patented : No
Drug : ZYFLO CR
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 22052
Country : US
Patented : No
Drug : REQUIP XL
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 22008
Country : US
Patented : No
Drug : BUPROPION HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 202775
Country : US
Patented : No
Drug : BUPROPION HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 202774
Country : US
Patented : No
Drug : MORPHABOND ER
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 206544
Country : US
Patented : Yes
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
